Paralos Bioscience turns research designs into phage tools while pursuing drug delivery
A research team can have a promising set of protein designs and still need the physical materials to test them. Paralos Bioscience offers to turn those designs into custom phage preparations, giving laboratories a way to buy that production step without commissioning a full discovery program. The company works with M13, a virus that infects bacteria. Its research service is aimed at academic, industry and institutional teams with defined peptide, protein or compatible antibody-fragment sequences.
From sequence to research material
Phage display places a candidate peptide or protein on a virus particle while linking it to the DNA that identifies it. Researchers can use that connection to investigate which candidates bind to a target.
Paralos offers either separate preparations for individual designs or a defined pool containing a set of variants. The choice lets a lab match the material to its experiment: individual tubes support separate comparisons, while a pool can be used for a screening workflow.
Individual constructs include full-vector sequence verification. A pooled library follows a quote-specific quality-control plan and does not automatically include that verification for every member.
A standard order does not include finding a binder or measuring whether a candidate works. The customer or a screening partner handles selection and validation, unless further work is separately agreed. The materials are for research use only.